Literature DB >> 32589726

Navigating the narrow bridge to CAR T-cell therapy.

Joanna C Yang1,2, John P Plastaras3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32589726      PMCID: PMC7362351          DOI: 10.1182/bloodadvances.2020002346

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


× No keyword cloud information.
  4 in total

1.  Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma.

Authors:  Austin J Sim; Michael D Jain; Nicholas B Figura; Julio C Chavez; Bijal D Shah; Farhad Khimani; Aleksandr Lazaryan; Gabriel Krivenko; Marco L Davila; Hien D Liu; Aaron D Falchook; Saurabh Dahiya; Aaron P Rapoport; Sungjune Kim; Frederick L Locke; Timothy J Robinson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-06-05       Impact factor: 7.038

2.  Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

Authors:  Sattva S Neelapu; Frederick L Locke; Nancy L Bartlett; Lazaros J Lekakis; David B Miklos; Caron A Jacobson; Ira Braunschweig; Olalekan O Oluwole; Tanya Siddiqi; Yi Lin; John M Timmerman; Patrick J Stiff; Jonathan W Friedberg; Ian W Flinn; Andre Goy; Brian T Hill; Mitchell R Smith; Abhinav Deol; Umar Farooq; Peter McSweeney; Javier Munoz; Irit Avivi; Januario E Castro; Jason R Westin; Julio C Chavez; Armin Ghobadi; Krishna V Komanduri; Ronald Levy; Eric D Jacobsen; Thomas E Witzig; Patrick Reagan; Adrian Bot; John Rossi; Lynn Navale; Yizhou Jiang; Jeff Aycock; Meg Elias; David Chang; Jeff Wiezorek; William Y Go
Journal:  N Engl J Med       Date:  2017-12-10       Impact factor: 91.245

3.  Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas.

Authors:  Stephen J Schuster; Jakub Svoboda; Elise A Chong; Sunita D Nasta; Anthony R Mato; Özlem Anak; Jennifer L Brogdon; Iulian Pruteanu-Malinici; Vijay Bhoj; Daniel Landsburg; Mariusz Wasik; Bruce L Levine; Simon F Lacey; Jan J Melenhorst; David L Porter; Carl H June
Journal:  N Engl J Med       Date:  2017-12-10       Impact factor: 91.245

4.  Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion.

Authors:  Michael R Bishop; Richard T Maziarz; Edmund K Waller; Ulrich Jäger; Jason R Westin; Joseph P McGuirk; Isabelle Fleury; Harald Holte; Peter Borchmann; Christopher Del Corral; Ranjan Tiwari; Özlem Anak; Rakesh Awasthi; Lida Pacaud; Vadim V Romanov; Stephen J Schuster
Journal:  Blood Adv       Date:  2019-07-23
  4 in total
  1 in total

1.  Adjuvant Scrotal Radiation Therapy As Bridging Therapy to Chimeric Antigen Receptor T-Cell Following Extramedullary Relapse in B-Cell Acute Lymphoblastic Leukemia.

Authors:  Colton Ladbury; Amandeep Salhotra; Savita Dandapani
Journal:  Cureus       Date:  2021-12-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.